Immunopathogenic Treatment Options for Psoriasis Patients Under a Restrictive Reimbursement Environment
, , and
Jul 22, 2021
About this article
Published Online: Jul 22, 2021
Page range: 158 - 166
Received: Jun 11, 2020
Accepted: Mar 01, 2021
DOI: https://doi.org/10.2478/prolas-2021-0025
Keywords
© 2020 Ilona Hartmane et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Hartmane, Ilona
Clinical Centre of Skin and Sexually Transmitted DiseasesLatvia
Department of Dermatology, Rīga Stradiņš UniversityLatvia
Ivdra, Iveta
Clinical Centre of Skin and Sexually Transmitted DiseasesLatvia
Department of Dermatology, Rīga Stradiņš UniversityLatvia
Mikažāns, Ingmārs
Clinical Centre of Skin and Sexually Transmitted DiseasesLatvia
Department of Dermatology, Rīga Stradiņš UniversityLatvia
Bondare-Ansberga, Vanda
Clinical Centre of Skin and Sexually Transmitted DiseasesLatvia